Changes of PSMA expression on [18F]PSMA1007 PET are not correlated with morphological changes in patients with metastatic renal cell cancer undergoing tyrosine kinase and checkpoint inhibitor treatment

被引：0
|
作者：
Kunte, Sophie [1 ]
Unterrainer, Lena [2 ,3 ]
Unterrainer, Marcus [4 ]
Holzgreve, Adrien [1 ]
Rodler, Severin [5 ]
Kunz, Wolfgang [6 ]
Stief, Christian
Bartenstein, Peter
Staehler, Michael [5 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Munich, Germany
[3] UCLA, Dept Nucl Med, Los Angeles, CA USA
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Urol, Munich, Germany
[6] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1052
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy
    Mittlmeier, L.
    Unterrainer, M.
    Rodler, S.
    Todica, A.
    Albert, N. L.
    Burgard, C.
    Cyran, C. C.
    Kunz, W. G.
    Ricke, J.
    Bartenstein, P.
    Stief, C. G.
    Staehler, M.
    Ilhan, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S283 - S284
  • [2] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
    L. M. Mittlmeier
    M. Unterrainer
    S. Rodler
    A. Todica
    N. L. Albert
    C. Burgard
    C. C. Cyran
    W. G. Kunz
    J. Ricke
    P. Bartenstein
    C. G. Stief
    H. Ilhan
    M. Staehler
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2031 - 2037
  • [3] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
    Mittlmeier, L. M.
    Unterrainer, M.
    Rodler, S.
    Todica, A.
    Albert, N. L.
    Burgard, C.
    Cyran, C. C.
    Kunz, W. G.
    Ricke, J.
    Bartenstein, P.
    Stief, C. G.
    Ilhan, H.
    Staehler, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 2031 - 2037
  • [4] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing first line tyrosine kinase or checkpoint inhibitor therapy.
    Staehler, Michael D.
    Kunte, Sophie
    Holzgreve, Adrien
    Unterrainer, Marcus
    Blajan, Iulia
    Stief, Christian G.
    Bartenstein, Peter
    Casuscelli, Jozefina
    Unterrainer, Lena
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [5] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine-kinase and check-point inhibitor therapy - preliminary results
    Mittlmeier, Lena
    Unterrainer, Marcus
    Todica, Andrei
    Cyran, Clemens
    Rodler, Severin
    Bartenstein, Peter
    Stief, Christian
    Staehler, Michael
    Ilhan, Harun
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [6] PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
    L. M. Mittlmeier
    M. Unterrainer
    A. Todica
    C. C. Cyran
    S. Rodler
    P. Bartenstein
    C. G. Stief
    H. Ilhan
    M. Staehler
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2216 - 2217
  • [7] PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
    Mittlmeier, L. M.
    Unterrainer, M.
    Todica, A.
    Cyran, C. C.
    Rodler, S.
    Bartenstein, P.
    Stief, C. G.
    Ilhan, H.
    Staehler, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (09) : 2216 - 2217
  • [8] Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on 18F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression
    Mittlmeier, Lena M.
    Ledderose, Stephan T.
    Schott, Melanie
    Brendel, Matthias
    Beyer, Leonie
    Theurich, Sebastian
    Mayr, Doris
    Walz, Christoph
    Kunz, Wolfgang G.
    Ricke, Jens
    Bartenstein, Peter
    Ilhan, Harun
    Staehler, Michael
    Unterrainer, Marcus
    DIAGNOSTICS, 2021, 11 (03)
  • [9] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Chikatamarla, Venkata Avinash
    Okano, Satomi
    Jenvey, Peter
    Ansaldo, Alexander
    Roberts, Matthew J.
    Ramsay, Stuart C.
    Thomas, Paul A.
    Pattison, David A.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [10] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Venkata Avinash Chikatamarla
    Satomi Okano
    Peter Jenvey
    Alexander Ansaldo
    Matthew J. Roberts
    Stuart C. Ramsay
    Paul A. Thomas
    David A. Pattison
    EJNMMI Research, 11
12345